Ultralife (NASDAQ:ULBI), a global provider of advanced high-energy power and communications systems, reported a net loss of $7.4 million for its fourth quarter on Tuesday.
The results were heavily impacted by non-cash asset impairment costs, which masked a period of otherwise stable operational performance for the New York-based manufacturer.
On a per-share basis, the company reported a loss of 45 cents.
However, when adjusted for the aforementioned impairment charges, Ultralife’s earnings stood at 12 cents per share.
The company, which serves diverse markets including government, defense, and medical sectors, posted revenue of $48.5 million for the three-month period.
For the full year 2025, Ultralife reported a total net loss of $5.9 million, or 35 cents per share.
Total annual revenue reached $191.2 million.
The company's performance reflects the ongoing integration of recent acquisitions and the recalibration of its supply chain to meet fluctuating demand in the global defense sector, particularly for its specialized radio power systems and primary battery technologies.